Tapashi Dalvi

1.3k total citations
41 papers, 732 citations indexed

About

Tapashi Dalvi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Tapashi Dalvi has authored 41 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 10 papers in Genetics. Recurrent topics in Tapashi Dalvi's work include Advanced Breast Cancer Therapies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and BRCA gene mutations in cancer (7 papers). Tapashi Dalvi is often cited by papers focused on Advanced Breast Cancer Therapies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and BRCA gene mutations in cancer (7 papers). Tapashi Dalvi collaborates with scholars based in United States, United Kingdom and Japan. Tapashi Dalvi's co-authors include Gladys Block, Mark Hudes, Edward P. Norkus, Christopher D. Jensen, Ellen B. Fung, Les G. Wong, Wei Li, Andrew E. Scharlach, Nina Holland and Patricia B. Crawford and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Tapashi Dalvi

38 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tapashi Dalvi United States	13	205	159	136	130	93	41	732
Carol Chute United States	6	146 0.7×	147 0.9×	186 1.4×	133 1.0×	109 1.2×	6	740
M.J. Stampfer United States	10	247 1.2×	194 1.2×	195 1.4×	115 0.9×	170 1.8×	18	939
Archana J. McEligot United States	13	217 1.1×	71 0.4×	206 1.5×	91 0.7×	193 2.1×	37	845
Hyun Ja Kim South Korea	18	158 0.8×	232 1.5×	290 2.1×	242 1.9×	149 1.6×	59	1.1k
Maria Hedelin Sweden	16	249 1.2×	147 0.9×	146 1.1×	121 0.9×	191 2.1×	25	984
Melania Assedi Italy	14	243 1.2×	115 0.7×	236 1.7×	51 0.4×	140 1.5×	37	786
Gerson Shigueaki Hamada Japan	18	184 0.9×	122 0.8×	143 1.1×	106 0.8×	225 2.4×	39	796
Paula Berstad Norway	15	372 1.8×	115 0.7×	231 1.7×	176 1.4×	123 1.3×	46	873
Silke Hermann Germany	17	330 1.6×	118 0.7×	201 1.5×	37 0.3×	100 1.1×	32	903
TM Mack Japan	2	187 0.9×	145 0.9×	107 0.8×	107 0.8×	130 1.4×	4	656

Countries citing papers authored by Tapashi Dalvi

Since Specialization

Citations

This map shows the geographic impact of Tapashi Dalvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tapashi Dalvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tapashi Dalvi more than expected).

Fields of papers citing papers by Tapashi Dalvi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tapashi Dalvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tapashi Dalvi. The network helps show where Tapashi Dalvi may publish in the future.

Co-authorship network of co-authors of Tapashi Dalvi

This figure shows the co-authorship network connecting the top 25 collaborators of Tapashi Dalvi. A scholar is included among the top collaborators of Tapashi Dalvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tapashi Dalvi. Tapashi Dalvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fennell, Dean A., et al.. (2024). P2.14B.05 eVOLVE-Meso: A Global Phase 3 Study of First-Line Volrustomig Plus Chemotherapy in Unresectable Pleural Mesothelioma. Journal of Thoracic Oncology. 19(10). S281–S281. 2 indexed citations

Reinmuth, Niels, Óscar Juan, Dariusz M. Kowalski, et al.. (2024). Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study. Clinical Cancer Research. 30(18). 4055–4067. 5 indexed citations

Chen, Yuanbin, Luis Paz‐Ares, Niels Reinmuth, et al.. (2022). Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report. JTO Clinical and Research Reports. 3(6). 100330–100330. 27 indexed citations

Stenehjem, David D., Sudhir Unni, Hillevi Bauer, et al.. (2021). BRCA testing and outcomes in women with breast cancer. Breast Cancer Research and Treatment. 186(3). 839–850. 8 indexed citations

Cronin‐Fenton, Deirdre, Tapashi Dalvi, Naimisha Movva, et al.. (2021). PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study. Scientific Reports. 11(1). 16892–16892. 6 indexed citations

Hedgeman, Elizabeth, Mette Nørgaard, Tapashi Dalvi, et al.. (2021). Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in Denmark. Cancer Epidemiology. 73. 101976–101976. 1 indexed citations

Koh, Su‐Jin, Shozo Ohsumi, Masato Takahashi, et al.. (2021). Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study. Breast Cancer. 29(1). 92–102. 3 indexed citations

Collins, Jenna, Beth Nordstrom, Kimmie McLaurin, et al.. (2021). A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status. Oncology and Therapy. 9(2). 575–589. 34 indexed citations

O’Shaughnessy, Joyce, Christine Brezden‐Masley, Marina Elena Cazzaniga, et al.. (2020). Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study. Breast Cancer Research. 22(1). 114–114. 26 indexed citations

10.

Schabath, Matthew B., Tapashi Dalvi, Hongyue Dai, et al.. (2019). <p>A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer</p>. Cancer Management and Research. Volume 11. 9469–9481. 1 indexed citations

11.

Nunes, Anthony P., Caihua Liang, William J. Gradishar, et al.. (2019). U.S. Prevalence of Endocrine Therapy–Naïve Locally Advanced or Metastatic Breast Cancer. Current Oncology. 26(2). 180–187. 6 indexed citations

12.

Dalvi, Tapashi, Kimmie McLaurin, Beth Nordstrom, et al.. (2019). Abstract P1-09-13: A real world evidence study of BRCA mutations and survival in HER2-negative breast cancer. Cancer Research. 79(4_Supplement). P1–9. 2 indexed citations

13.

Schabath, Matthew B., Tapashi Dalvi, Hongyue Dai, et al.. (2017). P1.01-042 Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S475–S476. 1 indexed citations

14.

Dalvi, Tapashi, Karen A. Gelmon, Rebecca Dent, et al.. (2017). BREAKOUT: A cross-sectional, prospective, observational study of germline BRCA mutation (gBRCAm) prevalence and real-world outcomes among patients (pts) with HER2-negative (HER2-ve) metastatic breast cancer (mBC). Annals of Oncology. 28. v105–v105.

15.

Beebe‐Dimmer, Jennifer, Jon P. Fryzek, Cecilia Yee, et al.. (2016). Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival. Clinical Epidemiology. Volume 8. 743–750. 79 indexed citations

16.

Danese, Mark D., Robert I. Griffiths, Michelle Gleeson, et al.. (2016). Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy. Leukemia & lymphoma. 58(5). 1094–1104. 26 indexed citations

17.

Block, Gladys, Christopher D. Jensen, Torin Block, et al.. (2009). The Work and Home Activities Questionnaire: Energy Expenditure Estimates and Association With Percent Body Fat. Journal of Physical Activity and Health. 6(s1). S61–S69. 12 indexed citations

18.

Block, Gladys, Christopher D. Jensen, Jason D. Morrow, et al.. (2008). The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radical Biology and Medicine. 45(4). 377–384. 92 indexed citations

19.

Block, Gladys, Christopher D. Jensen, Edward P. Norkus, et al.. (2007). Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study. Nutrition Journal. 6(1). 30–30. 127 indexed citations

20.

Dalvi, Tapashi, Alison J. Canchola, & Pamela L. Horn‐Ross. (2007). Dietary patterns, Mediterranean diet, and endometrial cancer risk. Cancer Causes & Control. 18(9). 957–966. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact